ACH
TMCI icon

ArrowMark Colorado Holdings’s Treace Medical Concepts TMCI Stock Holding History

ArrowMark Colorado Holdings’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-134,866
Closed -$3.63M – 368
2021
Q3 		$3.63M Sell
134,866
-430
-0.3% -$11.8K 0.03% 263
2021
Q2 		$4.23M Buy
+135,296
New +$4.31M 0.03% 250

Other funds holding TMCI

CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ArrowMark Colorado Holdings's TMCI Position: Q4 2021 in Review

ArrowMark Colorado Holdings sold out of Treace Medical Concepts (TMCI) in Q4 2021, closing a stake of 134,866 shares — an estimated $3.63M sold.

ArrowMark Colorado Holdings first reported a position in TMCI in Q2 2021 and held it in 2 quarters. The position peaked at $4.23M in Q2 2021. 77 funds tracked by Wall St. Rank hold TMCI as of Q4 2021.

  • ArrowMark Colorado Holdings reported no remaining Treace Medical Concepts position as of Q4 2021 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 134,866 Treace Medical Concepts shares in Q4 2021, an estimated $3.63M.
  • ArrowMark Colorado Holdings first reported a position in Treace Medical Concepts in Q2 2021 and held it in 2 quarters.
  • ArrowMark Colorado Holdings's Treace Medical Concepts position peaked at $4.23M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.